123 filings
Page 4 of 7
8-K
vj22rif 81
15 Jul 19
Submission of Matters to a Vote of Security Holders
4:18pm
8-K
tpkjfth74bh586oi6ms
1 Jul 19
Entry into a Material Definitive Agreement
3:03pm
8-K
ii24xt xu1jxla
14 Jun 19
Submission of Matters to a Vote of Security Holders
5:25pm
8-K
vjopn0ygi rvq
1 May 19
Flex Pharma Reports First Quarter 2019 Financial Results
7:32am
8-K
icj8td0
6 Mar 19
Flex Pharma Reports Fourth Quarter and Fiscal 2018 Financial Results
7:26am
8-K
sogwm4
15 Feb 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:27pm
8-K
deamcw6a
4 Jan 19
Flex Pharma and Salarius Pharmaceuticals Announce Merger Agreement to Accelerate Clinical Development of Novel Epigenetic Therapy for Cancer
9:04am
8-K
6lgx7celo8purm62vbpy
28 Nov 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
7:58am
8-K
e2i6xjf
5 Nov 18
Flex Pharma Reports Third Quarter 2018 Financial Results
8:00am
8-K
zq57k
1 Oct 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:06pm
8-K
wcn9uv0jef 4o4rftp
15 Aug 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:32am
8-K
casswb7
1 Aug 18
Flex Pharma Reports Second Quarter 2018 Financial Results
8:10am
8-K
ybyw9q
25 Jul 18
Departure of Directors or Certain Officers
4:11pm
8-K/A
sp821ff b7h
20 Jun 18
Cost Associated with Exit or Disposal Activities
4:16pm
8-K
zjo3e697yu
13 Jun 18
Cost Associated with Exit or Disposal Activities
12:00am
8-K
2dicf93htvd5iz
8 Jun 18
Submission of Matters to a Vote of Security Holders
4:33pm
8-K
0jjrlec3aig3 uq
2 May 18
Flex Pharma Reports First Quarter 2018 Financial Results
8:33am
8-K
o0movw
26 Mar 18
Flex Pharma Reports Positive Topline Data from Exploratory Phase 2 Trial of FLX-787 in Multiple Sclerosis
12:00am
8-K
lecym7fm020 oh
7 Mar 18
Flex Pharma Reports Year End 2017 Financial Results
12:00am
8-K
ngvx 40mcd8y
5 Feb 18
Departure of Directors or Certain Officers
12:00am